Multimodality imaging techniques

Contrast Media and Molecular Imaging

Volumn 5, Issue 4, 2010, Pages 180-189

  Martí Bonmatí, Luis ^a,b   Sopena, Ramón ^a,c   Bartumeus, Paula ^a   Sopena, Pablo ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c Hospital Nueve de Octubre   (Spain)

Author keywords

Molecular imaging; Multimodality imaging; PET CT; PET MR

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RACLOPRIDE C 11; TECHNETIUM SULFUR COLLOID TC 99M; TETROFOSMIN TC 99M; TRACER;

CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SIGNAL PROCESSING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DATABASES, FACTUAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956162077     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.393     Document Type: Review

References (83)

1. Cormack AM. Representation of a function by its line integrals with some radiological applications. J Appl Phys 1964; 35: 2908-2913.
2. Kuhl DE, Hale J, Eaton WL. Transmission scanning: a useful adjunct to conventional emission scanning for accurately keying isotope deposition to radiographic anatomy. Radiology 1966; 87: 278-284.
3. Hounsfield GN. Computerized transverse axial scanning (tomography): part 1. Description of system. Br J Radiol 1973; 46: 1016-1022.
4. Townsend DW. Dual-modality imaging: combining anatomy and function. J Nucl Med 2008; 49: 938-955.
5. Hutton BF, Braun M. Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med 2003; 33: 180-192. (Pubitemid 36859497)
6. Townsend DW. Multimodality imaging of structures and function. Phys Med Biol 2008; 53: 1-39.
7. Hasegawa BH, Gingold EL, Reilly SMS, et al. Description of a simultaneous emission-transmission CT system. Medical Imaging IV. Proc SPIE 1990; 1231: 50-60.
8. Carreras JL. Medicina nuclear. El desafío español. Rev Esp Med Nucl 2007; 26: 187-188.
9. Jaffer FA, Weissleder R. Molecular imaging in the clinical area. JAMA 2005; 293: 855-862.
10. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008; 452: 580-589.
11. Fass L. Imaging and cancer: a review. Mol Oncol 2008; 2: 115-152.
12. Blankespoor SC, Wu X, Kalki K, et al. Attenuation correction of SPECT using x-ray CT on an emission-transmission CT system: myocardial perfusion assessment. IEEE Trans Nucl Sci 1996; 43: 2263-2274.
13. Patton JA, Townsend DW, Hutton BF. Hybrid imaging technology: from dreams and vision to clinical devices. Semin Nucl Med 2009; 39: 247-263.
14. O' Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and Innovations. Semin Nucl Med 2006; 36: 258-266.
15. Seo Y, Mari C, Hasegawa H. Technological development and advances in single-photon emission computed tomography/ computed tomography. Semin Nucl Med 2008; 38: 177-198. (Pubitemid 351466914)
16. Intenzo CM, Jabbour S, Lin HC, et al. Scintigraphic imaging of body neuroendocrine tumors. Radiographics 2007; 27: 1355-1369.
17. Pacak K, Lineham WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization and treatment of pheocromocytoma. Ann Intern Med 2001; 134: 315-329.
18. Freitas JE. Adrenal cortical and medullary imaging. Semin Nucl Med 1995; 25: 235-250.
19. Leung A, Shapiro B, Hattner R. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997; 38: 1352-1357.
20. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med 2002; 32: 84-91.
21. Delbeke D, Heiko S, William H, et al. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med 2009; 39: 308-340.
22. 123I-MIBG scintigraphy. Nuklearmedicine 2004; 43: 164-170.
23. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm 2004; 19: 129-134.
24. Tharp K, Israel O, Hausmann J, et al. Impact of 131I SPECT-TAC images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imag 2004; 31: 1435-1442.
25. 99Tc-MIBI SPECT-CT in primary hyperparathyroidism. World J Surg 2006; 30: 76-83.
26. 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 2006; 47: 587-594.
27. Schillaci O, Filippi L, Danieli R, et al. Single-photon emission computed tomography/computed tomography in abdominal diseases. Semin Nucl Med 2007; 37: 48-61. (Pubitemid 44854755)
28. Hasegawa BH, Wong KH, Iwata K, et al. Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat 2002; 1: 449-458.
29. Schillaci O, Danieli R, Manni C, et al. Is SPECT/CT with hybrid camera useful to improve scintigraphy imaging interpretation? Nucl Med Commun 2004; 25: 705-710.
30. Bushnell DL, Kahn D, Huston B, et al. Utility of SPECT imaging for determination of vertebral metastases in patients with known primary tumors. Skeletal Radiol 1995; 24: 13-16.
31. Utsunomiya D, Shiraishi S, Imuta M, et al. Added value of SPECT/ CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 2006; 238: 264-271.
32. Strobel K, Burger C, Seifert B, et al. Characterization of focal bone lesions in the axial skeleton:Performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol 2007; 188: W467-W474.
33. Buck AK, Nekolla S, Ziegler S, et al. SPECT/CT. J Nucl Med 2008; 49: 1305-1319.
34. Even-Sapir E, Flusser G, Lerman H, et al. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med 2007; 48: 319-324.
35. 99mTc-methylene diphosphonate (MDP) bone single photon emission computed tomography (SPECT) in patients with knee osteoarthritis. Osteoarthritis Cartilage 2008; 16: 212-218.
36. Dieppe P, Cushnaghan J, Young P, et al. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993; 52: 557-563. (Pubitemid 23246656)
37. Pagenstert GI, A. Barg A, Leumann AG, et al. SPECT-CT imaging in degenerative joint disease of the foot and ankle. J Bone Joint Surg [Br] 2009; 91-B: 1191-1196.
38. Pneumaticos SG, Chatziioannou SN, Hipp JA, et al. Low back pain: prediction of short-term outcome of facet joint injection with bone scintigraphy. Radiology 2006; 238: 693-698.
39. Lee A, Emmett L, Van der WH, et al. SPECT/CT of femoroacetabular impingement. Clin Nucl Med 2008; 33: 757-762.
40. Fernando RA, Panchadhar S, Barwick T, et al. Initial experience of SPECT/CT in patients with problematic painful knee. Eur J Nucl Med Mol Imag 2008; 35: S379.
41. Vijayanathan S, Butt S, Gnanasegaran G. Advantages and limitations of imaging the muskuloskeletal system by conventional radiological, radionuclide and hybrid modalities. Semin Nucl Med 2009; 39: 357-368.
42. Wall HV, Lee A, Magee M, et al. Radionuclide bone scintigraphy in sports injuries. Semin Nucl Med 2010; 40: 16-30.
43. Bruggen W, Bleeker-Rovers CP, Boerman OC. et al, PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010; 40: 3-15.
44. Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med 2007; 37: 17-28.
45. Bar-Shalom R. Gallium SPECT/CT in lymphoma: the ups and down of functional imaging. Eur J Nucl Med Mol Imag 2005; 32: 1247-1249.
46. Carrera D, Bajem MT, Mora J, et al. Clinical utilility of 67Ga fused SPECT/CT scan images in patiens with lymphoma. Rev Esp Med Nucl 2006; 25: 3-9.
47. Husarik DB, Steinert HC. Single-photon emission computed tomography for sentinel node mapping in greast cancer. Semin Nucl Med 2007; 37: 29-33.
48. Lerman H, Metser U, Lievshitz G, et al. Lymphoscintigraphy sentinel node identification in patiens with breast cancer: the role of SPECT/CT. Eur J Nucl Med Mol Imag 2006; 33: 329-337.
49. Wagner A, Schicho K, Glaser C, et al. SPECT-CT for topographic maping of sentinel lymph nodes prior to gamma-probe -guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 2004; 32: 343-349.
50. Sherif A, Garke U, Torre Mide L, et al. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006; 50: 83-91. (Pubitemid 43850119)
51. Belhocine TZ, Scott AM, Even-Sapir E, et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006; 47: 957-967.
52. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003; 42: 1318-1333.
53. Utsunomiya D, Tomiguchi S, Shiraishi S, et al. Initial experience with X-ray CT based attenuation correction in myocardial perfusion SPECT imaging using a combined SPECT/CT system. Ann Nucl Med 2005; 19: 485-489.
54. Tonge CM, Ellul G, Pandit M, et al. The value of registration correction in the attenuation correction of myocardial SPECT studies using low resolution computed tomography images. Nucl Med Commun 2006; 27: 843-852.
55. Gaemperli O, Schepis T, Kallf V, et al. Validation of a new cardiac fusion software for three dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imag 2007; 34: 1097-1106.
56. Schepis T, Gaemperli O, Koepfli P, et al. Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. Eur J Nucl Med Mol Imag 2007; 34: 11-19.
57. Madsen MT. Recent advances in SPECT imaging. J Nucl Med 2007; 48: 661-673.
58. Mueller B, O'Connor MK, Blevis I, et al. Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med 2003; 44: 602-609. (Pubitemid 39663429)
59. Garcia EV, Tsukerman L, Keidar Z. A new solid state, ultra fast cardiac multi-detector SPECT system. J Nucl Cardiol 2008; 14: S3.
60. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379.
61. Townsend DW. Positron emission/computed tomography. Semin Nucl Med 2008; 38: 152-166.
62. Quan V, Ho L, Montion R, et al. Assessment of radiation exposure from CT during PET/CT imaging. J Nucl Med 2007; 48: 439P.
63. 18F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanism of tumor localization. Semin Nucl Med 2007; 37: 400-419.
64. Putzer D, Gabriel M, Hennnger B, et al. Bone metastasis in patients with Neuroendocrine tumor: Ga68-DOTA-Tyr3-Octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med 2009; 50: 1214-1221.
65. Czermin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET-CT: literature based evidence as of September 2006. J Nucl Med 2007; 48 (suppl 1): 78S-88S.
66. 18F-Fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 2009; 50: 1020-1027.
67. Grégorie V, Haustermans K, Geets X. et al PET-Based treatment planning in radiotherapy: a new standard? J Nucl Med 2007; 48: 68s-77s.
68. Whitwell JL, Jack C. Neuroimaging in dementia. PET Clin 2007; 2: 15-24.
69. Klunk WE, Engler HNordberg, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55: 306-219.
70. Carne RP, O'Brrien TJ, Kilpratic CG, et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain 2004; 127: 2276-2285.
71. Antonini A, Leenders KM, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997; 120: 2187-2195.
72. Parsey RV, Man JJ. Applications of positron emission tomography in psychiatry. Semin Nucl Med 2003; 33: 129-135. (Pubitemid 36577055)
73. Derdeyn CP. Positron emission tomography imaging of cerebral ischemia. PET Clin 2007; 2: 35-44.
74. Hammers A, Linford-Hughes A. Opioid imaging. neuroimaging clinics. 2006; 16: 529-552.
75. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 2008; 94: 360-367.
76. Underwood SR, Bax JJ, Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation. Report of a study of the European Society of Cardiology. Eur Heart J 2004; 25: 815-836.
77. Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 2004; 11: 603-616. (Pubitemid 39341805)
78. Pichler BJ, Judenhofer MS, Wehrl HF. PET/MRI hybrid imaging: devices and initial results. Eur Radiol 2008; 18: 1077-1086.
79. Pichler BJ, Wehrl HF, Kolb A. Positron emission tomography/ magnetic resonance imagaging: the next generation of multi-modality imaging? Semin Nucl Med 2008; 38: 199-208.
80. Martí-Climent JM, Orieto E, García-Velloso MJ. Hybrid scanners in nuclear medicine. Rev Fis Med 2009; 10: 11-26.
81. Cherry SR. Multimodality imaging: beyond PET/CT and SPECT/CT. Semin Nucl Med 2009; 39: 348-353.
82. Kuhn TS. The Structure of Scientific Revolutions. University of Chicago Press: Chicago, IL, 1962.
83. 18F-fluoride positron emission tomography and positron emission tomography/ computed tomography. Semin Nucl Med 2007; 37: 462-469.